The suppression of atherogenesis after E-selectin tolerization is a new and highly desirable mechanism of action for this innovation in stroke prevention since 80% of ischemic strokes are caused by arterial occlusion secondary to atherosclerosis [33]. The gene discussed is SELE; the disease is atherosclerosis.